Home Calendar Movers Compare
S&P 500 762.70 +1.15% Nasdaq 716.92 +1.73% Dow 30 518.26 +0.59% Apple 337.00 +1.38% Nvidia 230.36 +0.84% Tesla 366.20 +2.27%
Pre-Market | 16 companies reporting this week
Home / Calendar / RPRX

RPRX

Royalty Pharma plc - Class A
BIOTECHNOLOGY · HEALTHCARE
Royalty Pharma Plc, headquartered in New York, is a leading entity in the biopharmaceutical royalty acquisition arena, specializing in the acquisition of royalties from established market drugs and promising development pipelines. The company's strategic focus on funding innovative therapies not onl...
$58.93
90-day price trend
+0.79% (+$0.46)
Volume 2.06M
52W High $64.38
52W Low $34.63
Market Cap $25.48B
← Back to Calendar Compare with Others →

What to Watch This Quarter

Based on historical data
Consensus EPS
$1.18
Whisper EPS
$1.24
5.0% above consensus
Last Quarter
$1.32
Current Streak
8 Beats
Avg Surprise (4Q)
+7.51%

Next Earnings Report

Reports in 46 days
Report Date Nov 4, 2026
Whisper Spread +5.04%
Consensus Estimate
$1.18
Official analyst average
Whisper Number
$1.24
What traders expect
Bullish Sentiment: The whisper number is 5.0% above consensus, suggesting traders expect a strong beat. The stock may be priced for upside surprise.

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q2 2026 Aug 5, 2026
1-Day: -0.85%
5-Day: +0.38%
Q1 2026 May 6, 2026
1-Day: -1.03%
5-Day: +1.83%
Q4 2025 Feb 11, 2026
1-Day: +1.24%
Q3 2025 Nov 5, 2025
1-Day: +0.89%
5-Day: -4.65%

Revenue & Financial Performance

Quarter Revenue YoY Growth Gross Margin Op Margin Net Income
Q4'25 $622.0M +4.8% 100.0% 62.4% $214.2M
Q3'25 $609.3M +7.9% 100.0% 70.1% $288.2M
Q2'25 $578.7M +7.7% 100.0% 36.3% $30.2M
Q1'25 $568.2M +0.1% 100.0% 94.0% $238.3M
Q4'24 $593.6M -0.4% 100.0% 60.9% $208.2M
Q3'24 $564.7M +5.3% 100.0% 130.2% $544.0M
Q2'24 $537.3M -0.2% 100.0% 50.2% $102.0M
Q1'24 $568.0M -17.0% 100.0% -13.0% $4.8M

Historical Earnings

Last 12 quarters
Quarter Date Consensus Whisper Actual EPS Surprise % Result
Q2 2026 Aug 5, 2026 $1.27 $1.34 $1.32 +3.94% Missed
Q1 2026 May 6, 2026 $1.18 $1.25 $1.30 +10.17% Beat
Q4 2025 Feb 11, 2026 $1.33 $1.47 $1.47 +10.53% Met
Q3 2025 Nov 5, 2025 $1.11 $1.12 $1.17 +5.41% Beat
Q2 2025 Aug 6, 2025 $1.03 $1.09 $1.14 +10.68% Beat
Q1 2025 May 8, 2025 $0.95 $0.99 $1.06 +11.58% Beat
Q4 2024 Feb 11, 2025 $1.05 $0.26 $1.15 +9.52% Beat
Q3 2024 Nov 6, 2024 $0.93 $1.00 $1.04 +11.83% Beat
Q2 2024 Aug 8, 2024 $0.97 $1.04 $0.96 -1.03% Missed
Q1 2024 May 9, 2024 $0.98 $1.08 $0.98 +0.00% Missed
Q4 2023 Feb 15, 2024 $1.00 $1.06 $1.52 +52.00% Beat
Q3 2023 Nov 8, 2023 $0.77 $0.82 $0.79 +2.60% Missed

Company Information

Symbol
RPRX
Company
Royalty Pharma plc - Class A
Market Cap
$25.48B
Sector
HEALTHCARE
Next Earnings
Nov 4, 2026